Vaccines

Universal flu vaccines have been the holy grail for many years – are we onto a breakthrough at last?

What are the lessons we must learn from the COVID-19 pandemic?

New technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment.

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Could dry vaccines help improve global access to the latest vaccine technologies?

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates